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agreement, shared decision making
Abstract
Background Little is known about agreement between patients and
physicians on content and outcomes of clinical discussions. A
common perception of content and outcomes may be desirable to
optimize decision making and clinical care.
Objective To determine patient–physician agreement on content
and outcomes of coronary heart disease (CHD) prevention discus-
sions.
Design Cross-sectional survey nested within a randomized CHD
prevention study.
Setting and participants University internal medicine clinic; 24
physicians and 157 patients.
Methods Following one clinic visit, we surveyed patients and
physicians on discussion content, decision making and final deci-
sions about CHD prevention. For comparison, we audio-recorded,
transcribed and coded 20 patient–physician visits. We calculated
percent agreement between patient ⁄physician reports, patient ⁄ tran-
scription reports and physician ⁄ transcription reports. We calculated
Cohens kappas to compare patient ⁄physician perspectives.
Results Patients and physicians agreed on whether CHD was
discussed in 130 visits (83%; kappa = 0.55; 95%CI 0.40–0.70). When
discussions occurred, they agreed about discussion content (pros
versus cons) in 53% of visits (kappa = 0.15; 95% CI )0.01–0.30)
and physicians recommendations in 73% (kappa = 0.44; 95% CI
0.28–0.66). Patients and physicians agreed on final decisions to take
medication in 78% (kappa = 0.58; 95% CI 0.45–0.71) and change
lifestyle in 69% (kappa = 0.38; 95% CI 0.24–0.53). They agreed less
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often, 43% (kappa = 0.13; 95% CI )0.11–0.37) about degree of
involvement in decision making. Audio-recorded results were
similar, but showed very low agreement between transcripts and
patients and physicians self-report on discussion content and
decision making.
Conclusions Disagreements about clinical discussions and decision
making may be common. Future work is needed to determine: how
widespread such agreements are; whether they impact clinical
outcomes; and the relative importance of the subjective experience
versus objective steps of shared decision making.
Background
Shared decision making (SDM) is increasingly
popular in clinical practice and even advocated
as an ideal decision making model for prefer-
ence-sensitive medical decisions.1 It is a process
that involves at least two parties (patient and
physician) who each participate in decision
making through sharing information, expressing
preferences and agreeing on a treatment deci-
sion.2 SDM is important and distinct from other
decision-making models, because it integrates
the clinical expertise of the physician with the
values and preferences of the patient.
To facilitate the process of shared decision
making, several frameworks have explicitly
described its components.3–6 As outlined in a
recent systematic review, these frameworks agree
that shareddecisionmaking includesdiscussionof
patients treatment options and their pros and
cons; expression and clarification of patients val-
ues and preferences; and an explicit process of
making or deferring a decision.7 Frameworks,
however, differentially endorse other components
(e.g. defining the problem, physician check for
understanding, arranging for follow-up), sug-
gesting these are less essential to the SDMprocess.
Building on common conceptions of shared
decision making, researchers have set about
measuring shared decisions and their impact on
clinical outcomes. Most work has focused on
patients or physicians perceptions that shared
decision making occurred8–12; and how decision
aids (i.e. multi-media tools designed to promote
shared decision making) and patients involve-
ment in decision making affect outcomes.13,14 By
contrast, little work has focused on the joint
patient–physician experience of shared decision
making or how that might impact outcomes.
Indeed, it is generally assumed that if a core set of
components are observed to be present by third
party review,15,16 the process of decision making
is sufficient to be shared. While several studies
reporting discordant patient–provider perceptions
of the clinical encounter support this assump-
tion,17–20 other recent work challenges it. 21–24
Several studies suggest that SDM may result
from more than a discussion about patients
options and values, and an apparent deci-
sion.19,20 One study concluded that both patients
and physicians frequently make assumptions
about the others understanding and do not fully
engage in the SDM process.9 Other studies show
that patients and physicians conceptualize
shared decision making differently than the
research community21,23,24 with patients, in
particular, conceptualizing SDM more in terms
of gaining respect, building trust and receiving
empathy than on information exchange or
expression of preferences.22 Studies such as these
suggest that querying both patients and physi-
cians about key information may be necessary to
capture a truly informed decision, and querying
them about their respective perceptions of
involvement may be necessary to understand
when decisions are truly shared.
Given this evidence, we propose that further
study of patients and physicians perceptions of
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clinical encounters (and how they relate to an
observational comparison) is warranted. Such
an analysis might help identify areas for future
improvements in the shared decision making
process and guide future measurement of shared
decision making.
Our objectives for this study, therefore, were
to examine the extent of agreement between
patients and physicians regarding the content
and outcomes of one common clinical discus-
sion, coronary heart disease (CHD) prevention,
and subsequently to compare patient and phy-
sician reports of visit content and outcomes to
coded transcriptions of their clinic visit.
Methods
Overview
To examine patient–physician agreement, we
performed a cross-sectional survey nested within
a randomized trial of heart disease prevention
(see Fig. 1). In the larger trial, after collecting
baseline data on demographics, CHD risk and
attitudes, we centrally randomized patients to
either a multi-component intervention or usual
care, and saw them for two additional study
visits over several months. The intervention in
this trial consisted of a computerized decision
aid and coaching tool administered at the second
study visit and a series of tailored adherence
reminders delivered between the second and
third study visits.
This paper focuses on data collected at the
second study visit, between June 2007 and
December 2009, when we surveyed both patients
and their physicians about the content and
outcomes of a clinic visit and audio-recorded a
sub-sample of visits to provide an observational
comparison of what actually happened. We
report the main outcomes of our trial (e.g. data
collected at the third study visit on adherence
and predicted CHD risk) and other secondary
outcomes (e.g. data from the second study visit
on intent to start specific therapies) in a separate
paper (Sheridan SL, Behrend L, Pignone MP
et al. under review). The University of North
Carolina at Chapel Hills Biomedical Institu-
tional Review Board (IRB) approved all study
procedures.
Setting
We conducted our study in one university
internal medicine clinic. This clinic employs a
total of 93 physicians, including 17 attendings
(physicians-in-practice) and 76 residents (physi-
cians-in-training), who were not part of our
research team and were thus eligible to partici-
pate in the study. Forty of these physicians
agreed to participate in the larger trial (including
16 attendings and 24 residents), but only 24 (all
16 attendings and 8 residents) had patients
enrolled in this study. All participating physi-
cians attended a 1-h educational session





















Figure 1 Study design. Solid lines
indicate design of larger randomized
trial. Dashed lines indicate design of
current nested study.
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CHD risk and risk reduction; highlight the value
of patient choice and involvement in decision
making; and provide resources to support
patient adherence, including action plans, pill-
boxes and smoking cessation quitlines.
Participants
The sample for this study included all 24 phy-
sicians and their 157 patients (range 1–20
patients per physician) who participated in the
larger trial and had complete participation
through the second study visit (100% of phy-
sicians, 96% of all patients from the larger
trial). Patients were eligible to participate in
both the larger trial and this sub-study if they
were presenting for care with an enrolled phy-
sician, were between 40 and 79 years old, had
no prior history of cardiovascular disease, dia-
betes mellitus, or other serious medical condi-
tion that limited their life expectancy to less
than 5 years, and were at moderate (6–10%) to
high risk (>10%) of heart disease over 10 years
based on a Framingham risk equation.25 We
excluded patients if they were presenting for
their first visit, had no cholesterol check within
the past 18 months, were unable to speak or
read English, or had extreme elevations of sys-
tolic blood pressure (>180 mmHg) or choles-
terol (>300 mg ⁄dl).
Procedure
This analysis focuses on data collected at the
second study visit of the larger randomized trial.
Patients randomized to the intervention group
presented 45 min early to a previously scheduled
clinic visit and viewed a computerized CHD
prevention decision aid with coaching compo-
nent. The decision aid educated patients about
their global CHD risk and the best available
treatment options (aspirin, blood pressure and
cholesterol medications, and smoking cessation),
and facilitated values clarification and a choice
among treatments. The coaching component
provided suggestions for overcoming barriers to
talking with their physician (e.g. the doctor
decides what we talk about; my doctor uses
words I dont understand) and for gaining
support for treatment (in the form of prescrip-
tions, referrals, or encouragement). Both had
undergone formative testing, including pilot
testing of the decision aid alone26 and cognitive
and usability testing of a revised decision aid
with the coaching component (Sheridan SL,
Turner AL, Pignone MP et al. available from
authors upon request). After viewing the deci-
sion aid, patients proceeded to a previously
scheduled visit with their regular physician.
Patients randomized to the control group did
not present early and received usual care (phy-
sician-provided risk factor management) from
their physician.
Following the clinic visit, a research assistant
gave self-administered post-visit surveys to all
patients to complete via pen-and-paper. To
reduce burden, the research assistant dropped
off post-visit surveys for physicians to complete
as time allowed during or after their clinic
schedule. Most (>80%) physicians filled out
surveys on the same day. Surveys asked patients
and their physicians about visit content and
outcomes using the same questions. To provide
an observational comparison to patient and
physician report, we also audio-recorded the
first consecutive 20 visits (including nine differ-
ent physicians with a range of one to five
patients per physician); half of these visits were
for patients in the intervention group and half
for patients in the control group. All audio-tapes
were transcribed verbatim and coded by two
independent coders for visit content.
Survey content
We structured the patient and physician surveys
for this analysis to capture agreement on visit
content central to SDM.7 At a minimum, SDM
requires the effective integration of the know-
ledge held by the physician and the values and
preferences held by the patient. Ideally, then,
both parties should agree on the following: that
a discussion occurred; whether the pros and
cons of treatment options were discussed; that
the patient expressed his or her preferences
regarding next steps and decisions; and that a
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final decision was made or actively deferred.
We adapted survey content from a prior study
of prostate cancer screening,27 which derived
questions based on key SDM concepts 2,7,28and
expert opinion, and cognitively tested content
to ensure quality and understanding.
In completing surveys, participants first
reported whether or not they had a CHD
prevention discussion during their clinic visit.
Participants who did not report having a CHD
discussion did not continue to answer questions.
If they did report having a CHD discussion, they
continued to report on details of the discussion.
They reported on discussion content in two ways:
by indicating whether they discussed mostly pros,
pros and cons, ormostly cons about changing risk
factors (such as high blood pressure or choles-
terol) or reducing overall chances of heart disease;
and by whether and howmuch patients expressed
their preferences about risk factor treatment
options (a lot, a little, or not really). They reported
on involvement in decision making by indicating
who made the final decision (physician alone;
physician with patient opinion; shared decision;
patient with physician opinion; patient alone).28
Finally, participants reported on physician rec-
ommendations and final decisions to take medi-
cines (including aspirin, blood pressure
medication, cholesterol medication, or smoking
cessation medication) or change their lifestyle
(including diet and exercise changes and smoking
cessation).
When both physician and patient participants
did not report having a CHD discussion and did
not continue to answer questions, data were
missing. When data were missing for only one
(either physician or patient) participant, we
assumed a no answer for questions with
dichotomous yes ⁄no outcomes (including phy-
sician recommendations and final decisions)
because no recommendations or final decisions
regarding CHD prevention could be made
without a CHD prevention discussion. For
nominal outcomes (discussion of pros or cons,
patient expression of preferences, and who made
the final decision), however, we made no
assumptions and report agreement only on data
that were available for both parties.
Coding visit transcript content
We coded visit transcripts to correspond with
survey content, similar to methods employed by
many observational studies of SDM.6,16,29,30
When determining the presence of a CHD pre-
vention discussion, we required a specific state-
ment about lowering chances of heart disease.
When coding for discussion content, we counted
the number of pros and cons discussed and then
categorized this into mostly pros, pros and cons,
or mostly cons. To code patient expression of
preferences, we counted the number of prefer-
ences patients expressed regarding treatment
features (such as cost) or regarding a course of
action (such as taking a blood pressure medi-
cation) and categorized them into a lot
(expressed three or more preferences), a little
(expressed one to two preferences), and not
really (did not express any preferences). To code
for who made the final decision, we used
Charles(1997) definition of shared decision
making,2 which requires both patient and phy-
sician to share information, express preferences,
and negotiate a decision. We counted whether
prevention options were discussed, if the physi-
cian and patient both expressed their preferences
about risk factor treatment options, and whether
a decision was made. We then combined these
factors into five categories (see Appendix 1 in
supporting information) of decision making to
match the answer options on participant sur-
veys: physician alone; physician with patient
opinion; shared decision; patient with physician
opinion; patient alone. Finally, to code physi-
cian recommendations and final decisions, we
required a specific statement of recommendation
or plan to take medication or make lifestyle
changes. Our two independent coders had very
high agreement for coding across content ques-
tions (kappa = 0.88–1.0).
Analysis
For each of the outcomes described above, we
calculated the percent agreement between (i)
patient and physician report (full sample), (ii)
patient and transcription report (sub-sample
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only), and (iii) physician and transcription
report (sub-sample only) after accounting for the
effects of clustering of patients within physi-
cians. We also compared patient and physician
report by calculating simple and weighted kappa
values, which measure the agreement beyond
chance between two variables and range from
almost perfect agreement (0.80–1.00) to poor or
no agreement (0.00–0.19), with negative values
indicating worse agreement than expected by
chance.31 To calculate standard errors for kappa
values, we used a bootstrap method, sampling
physicians with replacement and including in the
bootstrap sample all patients seen by the sam-
pled physician. This method preserved the cor-
relation structure of the patients within
physicians and allowed us to account for the
effect of clustering of patients within physicians.
For outcomes with low kappa values or low
percentage agreement, we examined and report
on patterns of disagreement.
We initially analysed our results by the inter-
vention and control groups of the larger ran-
domized trial. However, finding no difference












Mean age (range) 63 (40–79) 62 (40–78) 64 (45–77) 62 (45–75)
Female (%) 27 22 20 12
Race
White (%) 85 87 90 100
Black (%) 10 9 10 0
At least some college education (%) 90 90 95 100
Good self-perceived health status (%) 90 89 80 82
Mean CHD risk 11.3 11.3 13.3 13.8
Preferred participation in decision making about
CHD prevention
Patient decides alone (%) 3 3 5 6
Patient decides with physician opinion (%) 31 37 25 29
Share decision (%) 44 40 50 47
Physician decides with patient opinion (%) 11 8 10 6
Physician decides alone (%) 12 12 10 12












Mean age (range) 38 (28–75) 38 (27–75) 46 (29–75) 44 (29–57)
Female (%) 29 30 11 0
Current standing
Resident (%) 33 30 11 14
Attending physician (%) 67 60 89 86
Preferred participation in decision making about
CHD prevention
Patient decides alone (%) 4 4 11 0
Patient decides with physician opinion (%) 21 17 22 29
Share decision (%) 67 70 56 57
Physician decides with patient opinion (%) 8 9 11 14
Physician decides alone (%) 0 0 0 0
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across groups, we combined groups into our




In the full analysis, we included all 157 patients
and 24 physicians who were eligible for and
participated in our larger CHD prevention trial
(see Tables 1 and 2). The sub-sample analysis of
20 clinic visits involved 20 patients and 9
different physicians. See Fig. 2 for a flow dia-
gram of these samples.
Patients in our full sample were mostly white,
male, had at least some college education and a
good self-perceived health status. Their mean
predicted CHD risk over 10 years was 11.3%.
Most patients expressed a preference for shared
decision making about CHD prevention. Char-
acteristics of patients who agreed with physi-
cians about having CHD discussions (N = 103)
were similar to those of the full sample. Char-
acteristics of patients in the sub-sample were
also similar to those in the full sample, although
those in the sub-sample who reported discus-
sions were slightly more likely to be male.
Physicians in our full sample were mostly at-
tendings (physicians-in-practice) and most also
indicated a preference for shared decision mak-
ing about CHD prevention. The sub-sample of
physicians was slightly older and contained a
higher proportion of males and attendings than
the full sample. Those physicians reporting
CHD discussions in both the full sample and
sub-sample had similar characteristics to their
respective full groups.
Full sample analysis: patient–physician
agreement on visit content
CHD discussions
Patients and physicians agreed 83% of the time
(95% CI: 72–86%) about whether they had a
CHD prevention discussion during their clinic
visit (see Table 3), with a kappa value of 0.55
(95% CI: 0.40–0.70) indicating moderate agree-
ment. We found 27 cases where both patient and
physician agreed that no CHD prevention dis-
157 patient-physician clinic visits
completed  
130 visits where either patient 
or physician reported having 
CHD discussion 
20 clinic visits 
audiorecorded, 
transcribed and coded 
103 visits where both patient 
and physician agreed to 









17 transcribed visits 
where both patient and 
physician agreed to 
having CHD prevention 
discussion 




agreed no CHD 
discussion 
occurred 
Figure 2 Study flow diagram.
Patient-physician agreement on discussions, L Behrend et al.
 2010 Blackwell Publishing Ltd Health Expectations, 14 (Suppl. 1), pp.58–72
64
cussion occurred, and excluded these cases from
the remainder of the analysis. In 103 visits, both
the patient and physician agreed a discussion
occurred and in 27 visits, only one reported
having a CHD prevention discussion. In the
following sections, we report on the remaining
visits where either the patient or physician
reported that a discussion occurred.
Discussion content
Patients and their physicians agreed 53% of the
time (95% CI: 45–64%) about whether they
discussed mostly pros, pros and cons, or mostly
cons about changing risk factors or lowering
overall chances of heart disease (kappa = 0.15;
95% CI: )0.01–0.30). Table 4 illustrates the
pattern of agreement, with shaded boxes indi-
cating agreement. On 22% of visits the physician
Table 3 Patient and physician agree-






(95% CI) Kappa (95% CI)
Presence of CHD discussion (N = 157)
Reported they talked about CHD
Yes 103 83% 0.55
(0.40–0.70)No 27 (72–86%)
Content of discussion (N = 103)
Reported they talked about
Mostly pros 31 53%
(45–64%)
0.15
()0.01–0.30)Pros and cons 24
Mostly cons 0
Patient expressed preferences (N = 103)





Who made final decision (N = 103)
Patient alone 0 43%
(32–54%)
0.13
()0.11–0.37)Patient with physician opinion 5
Shared decision 34
Physician with patient opinion 3
Physician alone 2
Physician recommendation (N = 130)








Final decision (N = 130)



















Mostly pros (%) 30 21 1
Pros and cons (%) 22 23 0
Mostly cons (%) 1 0 0
Total percent agreement: 53% (45–64%).
Kappa: 0.15 ()0.01–0.30).
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reported discussing mostly pros while the patient
reported discussing both pros and cons. Simi-
larly, on 21% of visits the patient reported
discussing only pros while the physician
reported discussing pros and cons. We found
very little extreme disagreement in the form of
one participant indicating discussion of only
pros and the other indicating discussion of only
cons (1% on either side).
Patients and physicians agreed on only 41% of
visits (95% CI: 33–49%) about whether the
patient expressed preferences about risk factor
treatment options a lot, a little, or not really at all
during the clinic visit (see Table 5). The kappa
for this outcome (=0.16; 95% CI: 0.03–0.28)
was low and indicated poor agreement beyond
chance. The majority of disagreement favored
physician over-reporting of patient participa-
tion, with 9% of visits in which the physician
reported a lot of patient participation though the
patient reported not really any participation.
Involvement in decision making
Patients and physicians agreed during 43% of
visits (95% CI: 32–54%) about who made the
final decision (kappa = 0.13; 95% CI: )0.11 to
0.37). Disagreements were variable (see
Table 6), with both some patients and some
physicians reporting shared decisions when the
other party reported no role or an independent
role in the decision. Overall, as with the prefer-
ence analysis, there was a trend indicating that
physicians are more likely to perceive higher
patient involvement in decision making than the
patients themselves report. In sensitivity analy-
sis, collapsing the middle three categories of
decision making (for comparison of physician
alone, any sharing of decision, patient alone;
data not in tables) increased percent agreement
to 78% (CI 66–88%) with little change in kappa
(kappa = 0.05; 95% CI: )0.11 to 0.21).
Physician recommendations and final decisions
Patients and physicians agreed more frequently
regarding physician recommendations and final
decisions. They agreed 72% of the time (95%
CI: 66–79%) about recommendations to take
medicine and 75% of the time (95% CI:
65–84%) about recommendations to change
lifestyle. The kappa values for both outcomes
indicate moderate agreement beyond chance
[kappa = 0.40 (95% CI: 0.28–0.53) and 0.49
(95% CI: 0.32–0.66), respectively]. Patients and
physicians agreed 78% (95% CI: 71–86%) and
69% (95% CI: 62–77%) of the time about final
decisions to take medication and change life-
Table 5 Patient and physician agreement on patient
expression of preferences
Physician report
A lot A little Not really
Patient report
A lot (%) 15 10 2
A little (%) 18 18 9
Not really (%) 9 12 8
Total percent agreement: 41% (33–49%).
Kappa: 0.16 (0.03–0.28).
Table 6 Patient and physician agree-









Physician (%) 2 0 7 1 1
Physician with
patient input (%)
1 3 7 0 0
Shared (%) 5 6 33 13 4
Patient with
physician input (%)
0 2 9 5 1
Patient (%) 0 0 1 0 0
Total percent agreement: 43% (32–54%).
Kappa: 0.13 ()0.11–0.37).
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style. However, there was somewhat less agree-
ment (67%; 95% CI: 55–79%; kappa = 0.12;
95% CI: )0.09 to 0.34) about final decisions to
discuss again at a later visit.
Sub-sample analysis: patient and physician
agreement with observed visit content
CHD discussions
A majority of the time, coded transcriptions
agreed with both physicians (75%; N = 15 out
of 20) and patients (65%; N = 13 out of 20)
that a CHD discussion occurred (see Table 7).
For the remainder of the sub-sample analysis,
we excluded three visits during which patient,
physician, and transcription agreed that no
CHD prevention discussion occurred. Average
visit length in the remaining 17 visits was 22 min
(range 13–37 min).
Discussion content
We found fairly low agreement between coded
transcriptions and both physician and patient
report regarding whether the discussion covered
mostly pros, pros and cons, or mostly cons of
risk factor treatment options. Only seven out of
17 physician ⁄ transcription comparisons (44%)
and four out of 17 patient ⁄ transcription com-
parisons (24%) agreed on this outcome.
We found very low agreement when compar-
ing transcriptions and surveys regarding whether
and how much the patient expressed preferences.
Four out of 17 physician ⁄ transcription com-
parisons (27%) and four out of 17 patient ⁄
transcription comparisons (25%) agreed on
patient expression of preferences during the
clinic discussion.
Involvement in decision making
Agreement was also low with regard to involve-
ment in decision making. Only five physi-
cian ⁄ transcription comparisons (33%) and four
patient ⁄ transcription comparisons (32%) agreed
on who made the final treatment decision.
Collapsing the middle three categories (for com-
parison of physician alone, any sharing of deci-
sion, patient alone; data not in tables) increased
Table 7 Comparison of patient and physician report to coded transcriptions of clinic visits









Presence of CHD discussion
Reported they talked about CHD 15 75 13 65
Content of discussion
Mostly pros, pros and cons, mostly cons 7 44 4 24
Patient expressed preferences
A lot 0 27 1 25
A little 0 2
Not really 4 1
Who made final decision
Patient alone 0 33 0 32
Patient with physician opinion 0 1
Shared decision 2 2
Physician with patient opinion 3 1
Physician alone 0 0
Physician recommendation
Take medicine 12 71 15 88
Change lifestyle 13 76 14 82
Final decision
Take medicine 15 88 15 88
Change lifestyle 14 82 13 76
Discuss at next visit 11 65 13 76
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this agreement to 15 physician ⁄ transcription
comparisons (88%) and 13 patient ⁄ transcription
comparisons (76%).
Physician recommendations and final decisions
We found high agreement between transcrip-
tions and physician and patient report regarding
physician recommendations. Twelve physi-
cian ⁄ transcription comparisons (71%) agreed
on recommendations to take medicine and 13
(76%) agreed on recommendations to change
lifestyle. Fifteen (88%) and 14 (82%) patient ⁄
transcription comparisons agreed on these same
outcomes, respectively.
Agreement was also high regarding final deci-
sions. Fifteen (88%) of both physician and
patient ⁄ transcription comparisons agreed about
final decisions to take medicine. Fourteen phy-
sician ⁄ transcription comparisons (82%) and 13
patient ⁄ transcription comparisons (76%) agreed
about final decisions to change lifestyle. Finally,
11 physician ⁄ transcription comparisons (65%)
and 13 patient ⁄ transcription comparisons (76%)
agreed on final decisions to discuss at a later visit.
Discussion
Our analysis of patient–physician agreement on
the content and outcomes of CHD prevention
discussions indicated fair to moderate agreement
about presence of discussions, physician recom-
mendations, and final decisions to either take
medicine or change lifestyle. We found poor
agreement regarding discussion content (mostly
pros, pros and cons, or mostly cons; patient
expression of preferences) and involvement in
decision making. Coded transcriptions agreed
with patient and physician report on most out-
comes. However, it was clear that patient and
physician reports each did not agree well with
coded transcriptions on content of CHD dis-
cussions and involvement in decision making.
We are encouraged that patients and physi-
cians agreed in 83% of visits about presence of
CHD discussions and in 78% and 69% of clinic
visits, respectively, about final decisions to either
take medicine or change lifestyle. The lack of
agreement on discussions [and the lack of actual
discussions (n = 27 visits)] is perhaps not
unexpected given that we recruited patients who
were already scheduled for routine clinic
appointments in which other clinical matters
may have taken priority over CHD preven-
tion.32 However, the agreement we found about
final decisions is slightly lower than a previous
study reported regarding actions taken during
consultations,33 and leaves roughly one quarter
of clinic encounters where patients and physi-
cians did not agree about their final decisions.
Disagreement on this outcome could have
important clinical implications if physicians are
unable to provide the necessary support (such as
prescriptions for medication, diet counselling, or
referral to smoking cessation programs) to carry
out decisions. It could also have important
implications if physicians believe that their
patients have agreed to treatment regimens that
they have no real intention of following; prior
studies suggest this is an important concern.34
Although we are unclear what might have con-
tributed to this disagreement in our sample,
previous studies have found similar misunder-
standings to result from a lack of clear patient
communication of treatment preferences and
expectations.33,34 Other possible contributors
are patient factors such as literacy or educa-
tional level (though both are high overall in our
sample) or the communication style of the var-
ious physicians in the sample.
A result of greater concern is the finding of
poor agreement between patients and physicians
on measures of discussion content (discussion of
mostly pros, pros and cons, or mostly cons and
expression of patient preferences) and involve-
ment in decision making. Though we are
unaware of other studies examining patient–
physician agreement on these exact outcomes,
this is consistent with literature describing phy-
sicians tendencies to overestimate information
exchange35–37 and the extent of patient partici-
pation.9,38 Discussion of pros and cons and
patients expression of preferences are important
when considering the balance and depth of a
clinic discussion, and both are recognized as
essential components of the shared decision
making process.7 Disagreement about discussion
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of pros and cons about treatment options is
concerning as it could indicate an imbalanced
discussion, one that does not include all relevant
information, or one in which information is not
presented in ways that are accessible to the other
participant. Disagreement about expression of
patient preferences raises many of the same
concerns. Disagreement about who made the
final decision, on the other hand, is concerning
to the extent that physicians believe they are
allowing patients to participate in decision
making, but are not; this is the very pattern we
and others9,38 have observed. In addition, prior
research suggests that patients may value the
process of involvement even more than who
actually makes the final decision.21,24 This raises
the possibility that disagreements which sup-
press patient involvement may adversely affect
clinical outcomes such as satisfaction with care,
self-efficacy, or trust.13,39,40
Our sub-sample provides important insights
into the disagreements between patients and
physicians in our full sample and raises ques-
tions about how to best measure SDM. In the
sub-sample, like the full sample, there was poor
agreement on discussion of pros and cons, dis-
cussion of patient preferences, and involvement
in decision making. Here, however, the dis-
agreement was between patient and transcript or
physician and transcript. These findings have
different implications depending on the outcome
measure.
Poor patient-transcription or physician-tran-
scription agreement on discussion content
(including pros and cons and patient prefer-
ences) is consistent with other observational
studies reporting routine clinical decisions are
often made without a great deal of information
sharing7,36,37 and suggests that communication
within the clinical encounter needs improve-
ment. One potential way for improvement is for
physicians to tailor their communication style
based on patient factors such as literacy or
education level.41,42 In addition, physicians
should check patient understanding to help
improve agreement about discussion content 6,43
or follow-up via mail or email with summaries of
key information and decisions. Alternately,
physicians (or patients) might consider partici-
pation in programs that teach effective ways to
elicit (or discuss) patient preferences.44,45
Poor patient-transcription or physician-tran-
scription agreement on involvement in decision
making has different implications. This finding is
consistent with previous research indicating that
patients have trouble determining who made the
final clinical decisions and to what extent
involved parties participated.21,23,24 These same
studies suggest that patients and physicians
conceptualize SDM differently than the research
community. These findings suggest that our
brief, objective SDM assessment (and more
recent and extensive measures)46 may not align
with patients and physicians general percep-
tions of a shared decision. Some work suggests
that patients may conceptualize SDM more in
terms of gaining respect, building trust, and
receiving empathy than on information
exchange or expression of preferences.22 To
move the field forward, it will therefore be
important not only to better define patients and
physicians notions of shared decision making,
but also to determine what most impacts clinical
outcomes: the patients experience of SDM,
physicians experience of SDM, or external and
observational documentation of SDM. Which-
ever of these outcomes has the biggest impact
should then be incorporated as part of the core
SDM measure.
In considering such conclusions, we must
acknowledge the following limitations. First, our
sample size overall, along with wide confidence
intervals, limits the precision of our results.
Moreover, the results from comparisons to 20
coded transcriptions are hypothesis-generating
only. Because we recorded consecutive visits,
these might not be representative of consulta-
tions in general at this practice. Second, our
sample was not powered to detect differences in
agreement among those in the intervention and
control groups of our larger trial. It is possible
that such differences exist and could be detected
if a larger sample were examined. Third, there is
the potential for recall error as physicians may
not have had time to complete surveys immedi-
ately following the clinic visit. However, most
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physicians returned surveys on the same day
they were delivered and were able to use visit
notes in completing surveys, minimizing our
concern. Fourth, there are potential issues with
interpretation of survey questions, and alternate
measures may produce different results. We
designed our surveys to ask identical questions
to patients and physicians and used questions
that would explore the nature of and participa-
tion in the discussion. After we conducted this
study, Melbourne et al. 46 published their
adaptation of the 12-item OPTION scale to
measure joint perceptions of SDM, providing
data to suggest that some individuals have
problems understanding pros and cons lan-
guage and appear to better understand the
meaning of advantages and disadvantages.
Furthermore, different questions about expres-
sion of patient preferences may change agree-
ment; our responses for expression of patient
preferences ranged from a lot to not really and
did not include a hard zero, which could have
affected interpretation. Additionally, the new
dyadic OPTION scale asks about concerns,
worries, expectations, and ideas to explore
preferences and values and may yield different
results. In addition, we did not specify a time
frame for patient involvement, which might have
affected our comparisons with visit transcrip-
tions if participants perceived involvement in
decision making over time. Furthermore,
because CHD prevention allows for decisions to
be made over time, we may have underestimated
patient involvement with our measures, which
we intended to focus on one clinical visit. Fifth,
the firm criteria we used for coding visit tran-
scripts could have contributed to the disagree-
ment between transcripts and patient and
physician surveys; for example, coding the
number of preferences expressed did not allow
us to consider the strength of a preference,
which could underestimate the extent of parti-
cipation when a patient expresses fewer prefer-
ences but with greater emphasis. However, such
criteria are necessary for any coding scheme and
have been widely employed.6,16,29,30 Finally, it is
possible that participants in the study were
already sensitized to SDM, and our results may
not generalize to other populations that had not
been exposed to a similar intervention. Our
results also may not generalize to more diverse
patient populations, those with less education,
or those with less desire for shared decision
making about CHD prevention.
Limitations aside, we feel the clinical and
research community should be aware that
disagreements about the content of and partic-
ipation in clinical discussions may be common.
Although we found reasonably good agreement
on whether discussions occur, what recommen-
dations physicians made, and what final
decision was made, there was poor agreement
on content of discussions and involvement in
decision making. Future work is needed not
only to determine how widespread such dis-
agreements are in a more diverse population,
but also to what extent these disagreements
impact clinical outcomes such as satisfaction,
trust and adherence. Future research should
also continue to improve on the measurement
of shared decision making and its components
and investigate the relative importance of the
subjective experience versus objective steps of
SDM. It could be that combining the subjective
assessment of involvement with objective veri-
fication of adequate information exchange is
key to ensuring quality decision making.
Further, the disagreements we have described
indicate the need to intervene and improve
physician–patient communication and SDM.
Most often it is physicians who have the power
to set the tone of a clinic visit and give patients
the opportunity to express treatment prefer-
ences;47 yet they tend to overestimate informa-
tion exchange35–37 and the extent of patient
participation.9,38 Given these findings, investi-
gators should continue to explore how best to
facilitate clearer communication between
patients and their physicians.
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